Roberta De Matteis

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Low Density Lipoprotein

Ankylosing Spondylitis

Cardiovascular Risk Factors

Inflammatory Response

Top Venues

Nature communications

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Mary E Walker, Roberta De Matteis, Mauro Perretti, Jesmond Dalli
Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease. Nature communications 15 (1) (2024)
Esteban Alberto Gomez, Roberta De Matteis, Palita Udomjarumanee, Patricia B Munroe, Jesmond Dalli
An LGR6 frameshift variant abrogates receptor expression on select leukocyte subsets and is associated with viral infections. Blood 144 (4) (2024)
Esteban Alberto Gomez, Roberta De Matteis, Palita Udomjarumanee, Patricia B Munroe, Jesmond Dalli
An LGR6 frameshift variant abrogates receptor expression on select leukocyte subsets and is associated with viral infections. Blood 144 (4) (2024)
Mary E Walker, Roberta De Matteis, Mauro Perretti, Jesmond Dalli
Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease. Nature communications 15 (1) (2024)
Mary E Walker, Roberta De Matteis, Mauro Perretti, Jesmond Dalli
Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease. Nature communications 15 (1) (2024)
Esteban Alberto Gomez, Roberta De Matteis, Palita Udomjarumanee, Genes And Health Queen Mary University Of London, Patricia B Munroe, Jesmond Dalli
LGR6 frameshift variant abrogates receptor expression on select leukocyte subsets and associates with viral infections. Blood (2024)
Roberta De Matteis, Magdalena B Flak, Maria Gonzalez-Nunez, Shani Austin-Williams, Francesco Palmas, Romain A Colas, Jesmond Dalli
Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer. Science advances 8 (5) (2022)